BEIJING, CHINA · SINCE 1921+86 10 6915 6699
PUMCH北京协和医院
English
★National Leading Unit · National Center for Rare Diseases

Center for Rare Diseases & Complex Multidisciplinary Care (MDT)

National Leading Hospital of the National Rare Disease Diagnosis and Treatment Collaboration Network (covering 324 hospitals nationwide), National Rare Disease Specialized Ward

HERITAGE & OVERVIEW

Department Overview & Heritage

National Leading Hospital of the National Rare Disease Diagnosis and Treatment Collaboration Network, host of the National Rare Disease Registration Platform (over 40,000 cases registered in-depth). Chief editor of China's first 'Guidelines for the Diagnosis and Treatment of Rare Diseases'. In February 2024, the first independent specialized ward for rare diseases will be officially launched, with 34 MDT specialty groups for complex diseases, serving as a core national base to address the challenges of 'difficult access to care, difficult diagnosis, and difficult medication'.

With the spirit of 'Centennial Grand Ward Rounds', relying on 34 MDT expert groups, the rare disease specialized ward, and national key laboratories, we achieve a complete loop of 'clinical discovery—gene decoding—basic analysis—targeted therapy'.

Century-Old Heritage · Premier Specialties

Academic Standing & Clinical Excellence

National Leading Hospital of the National Rare Disease Diagnosis and Treatment Collaboration Network, host of the National Rare Disease Registration Platform (over 40,000 cases registered in-depth). Chief editor of China's first 'Guidelines for the Diagnosis and Treatment of Rare Diseases'. In February 2024, the first independent specialized ward for rare diseases will be officially launched, with 34 MDT specialty groups for complex diseases, serving as a core national base to address the challenges of 'difficult access to care, difficult diagnosis, and difficult medication'.

National Centers & Research Platforms

  • 🏛National Leading Hospital of the National Rare Disease Diagnosis and Treatment Collaboration Network (324 hospitals)
  • 🏛National Rare Disease Registration System (NRDRS)
  • 🏛National Key Laboratory for Complex Critical and Rare Diseases
  • 🏛Peking Union Medical College Hospital Rare Disease Independent Specialized Ward
  • 🏛34 MDT Multidisciplinary Consultation Centers for Complex Diseases
📍 Clinical Campuses:Dongdan Campus (Main Campus)

CLINICAL SCOPE

Core Indications & Conditions Treated

01Complex undiagnosed diseases with unclear diagnosis (patients who have been to multiple hospitals without a diagnosis for a long time)
02Single-gene rare diseases and hereditary metabolic disorders affecting multiple systems
03POEMS syndrome, Castleman disease, and autoinflammatory diseases
04Lymphangioleiomyomatosis (LAM), idiopathic pulmonary fibrosis, and other rare respiratory diseases
05Fabry disease, Pompe disease, mucopolysaccharidosis, and other lysosomal storage disorders
06Transthyretin amyloidosis (ATTR) cardiomyopathy/multiple neuropathy
07Osteogenesis imperfecta (brittle bone disease), achondroplasia, and other rare bone metabolic disorders
08Hereditary angioedema (HAE), neuromyelitis optica, and other immune-related rare diseases

EXCELLENCE IN CARE

Clinical Strengths & Advanced Capabilities

With the spirit of 'Centennial Grand Ward Rounds', relying on 34 MDT expert groups, the rare disease specialized ward, and national key laboratories, we achieve a complete loop of 'clinical discovery—gene decoding—basic analysis—targeted therapy'.

1

Multidisciplinary one-stop care in the independent specialized ward for rare diseases: daily joint ward rounds and interdisciplinary consultations by renowned experts from multiple specialties

2

Rapid molecular genetic etiology screening channels using whole exome sequencing (WES) and whole genome sequencing (WGS)

3

National rare disease registration system and multicenter clinical follow-up network, driving clinical trials for new drugs for rare diseases and synchronized international market entry

4

'Orphan drug' precise medication rapid green approval and long-term multidisciplinary comprehensive functional rehabilitation assessment

5

34 outpatient MDT specialty groups for complex diseases (covering pituitary, pancreas, musculoskeletal, cardiovascular, thoracic tumors, etc.), serving tens of thousands of patients

MEDICAL MASTERS

Lead Physicians & Specialists

7 Specialists
TX

Tian Xinping

田新平

Chief Physician, Professor, Doctoral Supervisor

🏅 Standing Committee Member, Chinese Rheumatology Association · Lead Specialist in Systemic Vasculitis

National authority in systemic vasculitis and Takayasu arteritis. Specializes in advanced biologic therapy for vasculitis, lupus crises, and pregnancy management in rheumatic disease patients.

ZL

Zhu Lan

朱兰

Chief Physician, Professor, Doctoral Supervisor

🏅 Chair of Obstetrics & Gynecology, PUMCH · President-Elect, Chinese Society of Ob/Gyn · Former Board Member, IUGA

Discipline leader in female pelvic medicine and reconstructive surgery in China. Renowned internationally for novel pelvic organ prolapse reconstruction and surgical management of congenital genital malformations.

GH

Guan Hongzhi

关鸿志

Chief Physician, Professor, Doctoral Supervisor

🏅 Vice Director of Neurology, PUMCH · Leader in Neuro-Infections & CSF Cytology

National pioneer in cerebrospinal fluid (CSF) cytology and neuro-infectious immunology, providing authoritative 'liquid biopsy' diagnostics for encephalitis and meningitis.

DY

Dai Yi

戴毅

Chief Physician, Professor, Doctoral Supervisor

Leading expert in neurogenetics and rare neuromuscular diseases, specializing in Fabry disease, Pompe disease, spinal muscular atrophy, and muscular dystrophies.

ZS

Zhang Shuyang

张抒扬

Chief Physician, Professor, Doctoral Supervisor, Changjiang Scholar

🏅 President, PUMCH · Changjiang Scholar Distinguished Professor · Principal Investigator, National Rare Diseases Registry System

President of PUMCH and leading investigator of the National Rare Diseases Registry System. World authority on cardiomyopathy, cardiac amyloidosis (ATTR), Fabry disease, and heart failure management.

LJ

Li Jian

李剑

Chief Physician, Professor, Doctoral Supervisor

🏅 Director of Hematology, PUMCH · Head of Plasma Cell Disorders Working Group

Director of Hematology at PUMCH and internationally renowned authority on POEMS syndrome and systemic AL amyloidosis, authoring definitive global clinical criteria.

CL

Chen Limeng

陈丽萌

Chief Physician, Professor, Doctoral Supervisor

🏅 Vice Director of Nephrology, PUMCH · Lead Investigator, National Rare Kidney Disease Network

National leader in rare tubular and tubulointerstitial kidney disorders, establishing China's Gitelman and Bartter syndrome clinical and genetic registry.

Inquire with Department

PUMCH International Medical Services provides outpatient appointments, multidisciplinary MDT consultations, and inpatient care enquiries.

PEKING UNION MEDICAL COLLEGE HOSPITAL

Center for Rare Diseases & Complex Multidisciplinary Care (MDT) · Inquire with Department

Plan your visit